Back to Peptide Library
Anxiolytic Nootropic Peptide

Selank

Thr-Lys-Pro-Arg-Pro-Gly-Pro • Calm & Cognition

Selank is a synthetic seven-amino-acid analog of the immune peptide tuftsin, studied for anxiety reduction, cognitive support, mood regulation, stress resilience, and GABA-related signaling without the sedation associated with conventional benzodiazepines.

At a glance

Selank Quick Reference

Nasal reported range
Members only
Sign in to view dosing details.
SubQ community range
Members only
Sign in to view dosing details.
Cycle
Members only
Sign in to view dosing details.
Research routes
Nasal Spray / SubQ Injection
Human literature primarily uses the nasal route
Overview

What Is Selank?

Selank is a synthetic heptapeptide composed of seven amino acids: Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed from tuftsin, a naturally occurring fragment of immunoglobulin G involved in immune regulation. Researchers added the Pro-Gly-Pro sequence to improve metabolic stability and create a peptide capable of producing central nervous system effects.

Selank was developed at the Institute of Molecular Genetics in Russia and is primarily described as an anxiolytic peptide with secondary nootropic and immunomodulatory research interest.

Unlike benzodiazepines, Selank is not designed to broadly suppress central nervous system activity. Research instead points to possible modulation of GABA-related signaling, enkephalin breakdown, monoamine pathways, neurotrophic signaling, and stress-related immune activity.

A reported generalized-anxiety study regimen used 2.7mg daily intranasally, divided as 900mcg three times daily. Separate Russian 0.15% nasal-drop protocols have also been described as 2–3 drops per nostril three times daily for 10–14 days.

Mechanism

Selank Mechanism of Action

Tuftsin-derived structure

Selank combines the tuftsin sequence with Pro-Gly-Pro, a structural modification intended to improve metabolic stability and support central nervous system activity.

GABA-related signaling

Preclinical work suggests modulation of GABA-related signaling rather than broad suppression of central nervous system activity. Its actions should not be treated as identical to those of benzodiazepines.

Enkephalins and monoamines

Research has examined enkephalin breakdown and serotonergic, dopaminergic, and noradrenergic signaling. These are proposed mechanisms, not a fully established human pathway.

Stress and neuroplasticity

Animal work explores stress-related immune activity and neurotrophic signaling. These findings provide research context for the calming and cognitive effects reported by users.

Research findings

Selank Benefits

Selank has more human research than many experimental peptides, but most clinical work comes from Russian studies that have not been broadly replicated in large Western trials.

Evidence: regional human studies and preclinical research

Anxiety Reduction

Small comparative human studies reported anxiety improvement with less sedation and cognitive impairment than the benzodiazepine comparators used in those trials. Comparative human study.

Cognitive Support

Attention, working memory, verbal fluency, and mental clarity are recurring research and community themes, although much of the mechanistic support is preclinical.

Calm Without Heavy Sedation

Clinical and community reports commonly describe reduced tension without the pronounced drowsiness or cognitive dulling associated with many conventional anxiolytics.

Stress Resilience

Preclinical and limited human work suggests regulation of stress-related cytokines, including IL-1β, IL-6, TNF-α, and IL-4.

BDNF & Neuroplasticity

Animal studies found changes in BDNF expression in the hippocampus and prefrontal cortex, offering a possible explanation for learning and memory effects.

Low Dependence Potential

Short published studies have not shown the tolerance, physical dependence, or withdrawal pattern associated with benzodiazepines, but they do not establish long-term risk.

Protocol planning

Selank Dosing Protocol

Members Access Only

Sign in or create a free account to view this content.

Preparation

Selank Reconstitution & Nasal Preparation

Nasal spray preparation example

10mg Selank in 5mL final volume

At 0.1mL per spray200mcg/spray

Nasal preparation

1
Prepare

Our reported diluent preference is 50% sterile, preservative-free 0.9% saline and 50% bacteriostatic 0.9% sodium chloride. The bacteriostatic component contains a preservative. Use a suitable metered bottle and clean handling.

2
Measure the final mixture

The example contains 10mg Selank in 5mL final liquid volume, using equal parts of the two diluents: 2.5mL sterile saline and 2.5mL bacteriostatic sodium chloride. This gives 2mg/mL.

3
Confirm pump output

At a measured 0.1mL per spray, 2mg/mL delivers 200mcg per spray. Check the bottle specification and actual output; another pump volume changes the amount per spray.

4
Storage

Keep refrigerated and protected from light according to the formulation instructions. Record the prep date in your research journal.

Reconstitution Example

10mg vial + 2mL BAC water

Result5mg/mL

SubQ vial preparation

1
Prepare

Wash hands, clean the work surface, and wipe vial stoppers with alcohol. Allow them to dry.

2
Add diluent slowly

Use a new sterile syringe and needle to add 2mL BAC water down the inside vial wall when compatible with the formulation.

3
Dissolve gently

Swirl or roll until dissolved; do not shake.

4
Storage

Store refrigerated at 2–8°C and protected from light, following the product instructions. Record the reconstitution date in your research journal.

N=1 reports

Selank Community Experience

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

  • The most consistent report is reduced background anxiety without sedation or a “medicated” feeling.
  • Some users report calmer social interactions and reduced physical tension, restlessness, or racing-heart sensations.
  • Improved verbal fluency, working memory, focus, and easier word recall are commonly described.
  • Effects are often described as subtle and natural rather than strongly sedating or stimulating.

Negative & Mixed Reports

  • Some users report no noticeable effect, especially with inconsistent or low-quality nasal products.
  • Results appear less consistent for severe panic disorder or severe social anxiety than for generalized or situational anxiety.
  • Headache, nasal irritation, fatigue, dizziness, restlessness, or sleep disruption are occasionally reported.
  • Perceived onset varies widely: some users notice effects within 10–20 minutes, while others report only a gradual shift over one to two weeks.
  • Late dosing can make it harder for some users to wind down, so morning and early-afternoon use is often preferred.
Stacking & synergy

Selank Stacking & Synergy

These are reported pairings and practical combinations. Introduce changes separately and track the effects of each compound.

Selank + Semax

The most common pairing. Selank provides a calming baseline while Semax is used for focus and cognitive drive. A human fMRI study found both affected amygdala-temporal connectivity, but no dosing trial has validated the stack.

Selank + BPC-157

These are sometimes combined for separate anxiety, gut, and tissue-repair goals. No published evidence establishes synergy.

Safety notes

Selank Side Effects & Safety

Selank has generally been described as well tolerated in short Russian clinical studies, but modern long-term safety, reproductive safety, and interaction data remain limited.

Selank affects GABA-related, serotonergic, dopaminergic, enkephalin, and immune pathways. Combining it with psychiatric medication, alcohol, or central nervous system depressants may produce effects that have not been adequately studied.

In Published Research

  • Short clinical studies did not identify the sedation, memory impairment, tolerance, or withdrawal pattern typical of benzodiazepines.
  • Long-term, reproductive, and formal interaction data remain limited.
  • Most human data comes from relatively small Russian studies.

What Users Report

  • Common: temporary nasal irritation, unusual taste, headache, or mild fatigue.
  • Less common: dizziness, restlessness, nausea, vivid dreams, or difficulty winding down when taken late.
  • Injection users may experience redness, tenderness, swelling, or bruising at the site.

Selank Precautions

Major Precautions
  • Avoid use with known hypersensitivity to Selank, tuftsin-related peptides, or formulation ingredients.
  • Pregnancy and breastfeeding have not been adequately studied.
  • Selank is not a substitute for urgent care during an acute psychiatric crisis, mania, psychosis, suicidal thoughts, or severe uncontrolled panic.
Use Caution With
  • Benzodiazepines or other GABAergic medications.
  • SSRIs, SNRIs, MAO inhibitors, tricyclic antidepressants, stimulants, or other psychiatric drugs.
  • Alcohol, sedatives, sleep medications, or other central nervous system depressants.
  • Autoimmune disease, immunosuppressive therapy, or significant immune dysfunction; the relevance of Selank's preclinical immunomodulatory activity is uncertain.
  • Use under age 18 because pediatric safety data is limited.
  • Drug Interactions: No comprehensive human interaction program has been conducted. Benzodiazepine combinations have been studied only in controlled clinical settings, and evidence for serotonergic or other psychiatric-medication combinations remains limited.
  • Monitoring: No standard laboratory-monitoring protocol exists. Track anxiety severity, mood, sleep, cognition, nasal irritation, and any unexpected behavioral changes.
Regulatory status: Selank is not FDA approved in the United States. Its human literature and prescription-product history are centered largely in Russia, which limits how broadly the evidence can be generalized.
Final verdict

Peptide Protocols Verdict on Selank

Not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.
Our opinionated opinion

Selank is a decent compound for anxiety reduction, focus, and calm mental performance without sedation. Clean nootropic effects that support both physical athletic training and day jobs with high-cognitive demands. Reliable, well-tolerated daily option with consistent positive feedback.

Stacks very well with Semax. Semax handles the cognitive side through BDNF and dopamine, while Selank is the anxiolytic counterpart, taking the edge off any overstimulation Semax can cause for some people. Run them together for 2 weeks, followed by 2–4 weeks off, both intranasal, mornings and early afternoon. Repeat as needed. We see others including ourselves get better results stacking them than running either alone. We have not seen major downsides reported, which makes it an easy daily addition for mental clarity and stress management.